Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/ISRCTN40512715
ISRCTN40512715CompletedNot Applicable

17-Alpha hydroxyprogesterone in Multiple pregnancies to Prevent Handicapped InfAnts

The Netherlands Organization for Health Research and Development (ZonMw) (The Netherlands)0 sites700 target enrollmentStarted: January 4, 2007Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
700
Study OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Sex
Female

Inclusion Criteria

  • •1. Women with a multiple pregnancy
  • •2. Gestational age between 15 and 19 weeks
  • •3. Aged 18 and older

Exclusion Criteria

  • •1. Major congenital anomaly of (one of) the fetuses
  • •2. Death of (one of) the fetuses
  • •3. Early signs of Twin-to-Twin Transfusion Syndrome
  • •4. Primary cerclage
  • •5. Previous preterm birth less than 34 weeks

Investigators

Sponsor
The Netherlands Organization for Health Research and Development (ZonMw) (The Netherlands)

Similar Trials

Completed
Phase 2
17OHP for Reduction of Neonatal Morbidity Due to Preterm Birth (PTB) in Twin and Triplet PregnanciesPreterm Birth
NCT00163020Obstetrix Medical Group321
Completed
Not Applicable
Single Injection 17-hydroxyprogesterone caproate in Preterm labour: a randomised controlled trial
ISRCTN22145023niversity of Malaya Medical Centre (Malaysia)256
Completed
Phase 2
17-alpha-hydroxyprogesterone caproate versus vaginal progesterone suppository for the prevention of preterm birth in women with a sonographic short cervixPreterm labour.Preterm spontaneous labour with preterm delivery Preterm labour with delivery NOS Preterm spontaneous labour with preterm delivery by caesarean section
IRCT2012082610664N1Tehran University of Medical Sciences Vice chancellor for research304
Completed
Phase 3
Effect of the progesterone injection in prevention of preterm labourPRETERM LABOUR.Preterm labour without delivery
IRCT2014101019222N2Kurdestan University of Medical Sciences100
Completed
Phase 2
The effect of progestrone on preterm labour in patient who are pregnant with ART teqniquepreterm labour.complication of labour and deliveryO60,O75
IRCT2012101611132N1Aburaihan Pharmacy company106
17-Alpha hydroxyprogesterone in Multiple... | Clinical Trial